Chapter 4 104 REFERENCES Alzheimer’s disease International. (2016). World Alzheimer Report 2016 Improving healthcare for people living with dementia COVERAGE, QUALITY AND COSTS NOW AND IN THE FUTURE About the report. http://www.alz.co.uk Alzheimer’s Disease International. (2018). From plan to impact Progress towards targets of the Global action plan on dementia. https://www.alz.co.uk/adi/pdf/from-plan-to-impact-2018.pdf American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (revised 4th ed.). American Psychiatric Association. Baune, B. T., & Renger, L. (2014). Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – A systematic review. Psychiatry Research, 219(1), 25–50. https://doi.org/10.1016/j.psychres.2014.05.013 Blair, M., Coleman, K., Jesso, S., Desbeaumes Jodoin, V., Smolewska, K., Warriner, E., Finger, E., & Pasternak, S. H. (2016). Depressive Symptoms Negatively Impact Montreal Cognitive Assessment Performance: A Memory Clinic Experience. Canadian Journal of Neurological Sciences, 43(4), 513– 517. https://doi.org/10.1017/cjn.2015.399 Borson, S., Frank, L., Bayley, P. J., Boustani, M., Dean, M., Lin, P. J., McCarten, J. R., Morris, J. C., Salmon, D. P., Schmitt, F. A., Stefanacci, R. G., Mendiondo, M. S., Peschin, S., Hall, E. J., Fillit, H., & Ashford, J. W. (2013). Improving dementia care: The role of screening and detection of cognitive impairment. In Alzheimer’s and Dementia (Vol. 9, Issue 2, pp. 151–159). Elsevier Inc. https://doi.org/10.1016/j. jalz.2012.08.008 Brunet, M. D., McCartney, M., Heath, I., Tomlinson, J., Gordon, P., Cosgrove, J., Deveson, P., Gordon, S., Marciano, S. A., Colvin, D., Sayer, M., Silverman, R., & Bhattia, N. (2013). There is no evidence base for proposed dementia screening. In BMJ (Online) (Vol. 346, Issue 7889). https://doi.org/10.1136/ bmj.e8588 Burn, A. M., Fleming, J., Brayne, C., Fox, C., & Bunn, F. (2018). Dementia case-finding in hospitals: A qualitative study exploring the views of healthcare professionals in English primary care and secondary care. BMJ Open, 8(3), e020521. https://doi.org/10.1136/bmjopen-2017-020521 Carson, N., Leach, L., & Murphy, K. J. (2018). A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. International Journal of Geriatric Psychiatry, 33(2), 379–388. https://doi. org/10.1002/gps.4756 Cordell, C. B., Borson, S., Boustani, M., Chodosh, J., Reuben, D., Verghese, J., Thies, W., & Fried, L. B. (2013). Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. In Alzheimer’s and Dementia (Vol. 9, Issue 2, pp. 141–150). Elsevier Inc. https://doi.org/10.1016/j.jalz.2012.09.011 Dautzenberg, G., Lijmer, J., & Beekman, A. (2020). Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls. International Journal of Geriatric Psychiatry, 35(3), 261–269. https://doi.org/10.1002/gps.5227 Davis, D. H. J., Creavin, S. T., Noel-Storr, A., Quinn, T. J., Smailagic, N., Hyde, C., Brayne, C., Mcshane, R., & Cullum, S. (2013). Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: A generic protocol for cross-sectional and delayed-verification studies. Cochrane Database of Systematic Reviews, 2013(3). https://doi.org/10.1002/14651858.CD010460
RkJQdWJsaXNoZXIy MTk4NDMw